Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
12.82 EUR | +0.63% | +1.91% | +30.55% |
May. 20 | BTIG Initiates Abivax at Buy Rating With $43 Price Target | MT |
May. 08 | Abivax: four abstracts to be presented on obefazimod | CF |
Sales 2024 * | 3.51M 3.82M | Sales 2025 * | 2.51M 2.73M | Capitalization | 802M 873M |
---|---|---|---|---|---|
Net income 2024 * | -163M -178M | Net income 2025 * | -176M -192M | EV / Sales 2024 * | 203 x |
Net cash position 2024 * | 87.4M 95.18M | Net cash position 2025 * | 44.68M 48.66M | EV / Sales 2025 * | 302 x |
P/E ratio 2024 * |
-4.63
x | P/E ratio 2025 * |
-4.78
x | Employees | 61 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 90.17% |
Latest transcript on Abivax
1 day | +0.47% | ||
1 week | +1.75% | ||
Current month | +1.75% | ||
1 month | -8.70% | ||
3 months | -1.54% | ||
6 months | +31.82% | ||
Current year | +30.35% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 66 | 23-05-04 | |
Didier Blondel
DFI | Director of Finance/CFO | - | 17-01-01 |
Sheldon Sloan
CTO | Chief Tech/Sci/R&D Officer | - | 23-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Founder | 65 | 13-12-03 | |
Kinam Hong
BRD | Director/Board Member | - | - |
Troy Ignelzi
BRD | Director/Board Member | 56 | 23-07-10 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-07 | 12.82 | +0.63% | 4 978 |
24-06-06 | 12.74 | +1.76% | 11,050 |
24-06-05 | 12.52 | +2.12% | 14,374 |
24-06-04 | 12.26 | -2.08% | 11,959 |
24-06-03 | 12.52 | -0.48% | 16,751 |
Real-time Euronext Paris, June 07, 2024 at 05:34 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+30.35% | 872M | |
+55.55% | 59.28B | |
+43.34% | 40.94B | |
-4.71% | 40.17B | |
-5.56% | 28.69B | |
+13.76% | 26.63B | |
-22.00% | 18.89B | |
+31.50% | 12.46B | |
+2.16% | 12.42B | |
+25.70% | 12.26B |
- Stock Market
- Equities
- ABVX Stock